Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7ACK

CDK2/cyclin A2 in complex with an imidazo[1,2-c]pyrimidin-5-one inhibitor

Summary for 7ACK
Entry DOI10.2210/pdb7ack/pdb
DescriptorCyclin-dependent kinase 2, Cyclin-A2, 8-cyclohexyl-6~{H}-imidazo[1,2-c]pyrimidin-5-one, ... (7 entities in total)
Functional Keywordscyclin-dependent kinase 2, substituted imidazo[1, 2-c]pyrimidin-5-one, inhibitor, cell cycle
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight128823.02
Authors
Skerlova, J.,Pachl, P.,Rezacova, P. (deposition date: 2020-09-11, release date: 2021-03-24, Last modification date: 2024-11-20)
Primary citationJansa, J.,Jorda, R.,Skerlova, J.,Pachl, P.,Perina, M.,Reznickova, E.,Heger, T.,Gucky, T.,Rezacova, P.,Lycka, A.,Krystof, V.
Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure.
Eur.J.Med.Chem., 216:113309-113309, 2021
Cited by
PubMed Abstract: Pharmacological inhibition of cyclin-dependent kinases has emerged as a possible treatment option for various cancer types. We recently identified substituted imidazo[1,2-c]pyrimidin-5(6H)-ones as inhibitors of cyclin-dependent kinase 2 (CDK2). Here, we report the synthesis of derivatives modified at positions 2, 3, 6 or 8 prepared using Suzuki-Miyaura cross-coupling, halogenation, Dimroth-type rearrangement and alkylation as the main synthetic methods. The compounds displayed micro- to submicromolar inhibition of CDK2/cyclin E activity. Binding of the most potent compound 3b to CDK2 was determined using isothermal titration calorimetry. The co-crystal structure of 3b in complex with fully active CDK2 was solved, revealing the binding mode of 3b in the ATP pocket and a hydrogen bonding interaction with hinge region residue Leu83. Evaluation against leukaemia cell lines revealed low cytotoxicity, which is in line with the high selectivity towards CDK2. This study demonstrates that substituted imidazo[1,2-c]pyrimidines can be exploited for future kinase inhibitor development.
PubMed: 33711765
DOI: 10.1016/j.ejmech.2021.113309
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon